NEW YORK (Reuters Health) - Although lower levels of LDL-cholesterol seem to correlate with higher rates of cancer, treatment with statin agents does not increase the risk of malignant neoplasia, according to a report in the August 20th online issue of the Journal of the American College of Cardiology.